420 with CNW – Federal Commission Supports Expanding Psychedelics and Cannabis Research for Military Veterans

A federal commission that was asked to generate recommendations which will help to improve how military veterans suffering from mental health issues are treated has come to an unexpected conclusion urging the legislative and executive branches of the U.S. federal government to do everything possible to ease research into psychedelics and marijuana.

After months of meetings, the commission, named Creating Options for Veterans’ Expedited Recovery (“COVER”), released its findings in a report authored in January. Surprisingly, this report hasn’t drawn as much attention as it deserves among the marijuana law reform movement and the media.

The panel, led by Jake Leinenkugel (a presidential nominee), asserted that psychedelics, such as MDMA and psilocybin, as well as marijuana, present promising ways to treat mental health conditions among military veterans.

The panel also noted that while medical marijuana and some psychedelics have been used while treating military veterans, the Schedule 1 status of these substances prevents the Department of Veterans Affairs (V.A.) from doing any research about the efficacy or risks of these treatment options.

Furthermore, the scheduling status of psychedelics and marijuana in the Controlled Substances Act makes it very hard for entities interested in doing research to obtain regulatory approval for the planned studies. The researchers are required to get permission from many federal government agencies, and some of those agencies are openly opposed to any medicinal use of marijuana.

The supply of research-grade marijuana, together with other controlled substances, is woefully inadequate. Reports also indicate that the marijuana available from the sole government-approved supplier in Mississippi is chemically closer to industrial hemp than to the marijuana which is available in the retail dispensaries in states where marijuana has been legalized.

For this reason, the COVER panel recommends that the legislature and the executive arms of the federal government compels NIDA (National Institute on Drug Abuse) to develop varieties of marijuana whose THC content is at par with the medical marijuana that patients are accessing in states with enabling marijuana laws. This will ensure that researchers engage in research whose findings have relevance to the community.

The panel also wrote that using medical marijuana and psychedelics as treatment options for military veterans has cost implications and yet there is limited information about the efficacy and risks associated with these products. The VA was therefore urged to conduct rigorous research so that answers can be obtained about medical cannabis and psychedelics.

In the same vein, physicians working with the VA need to be equipped with research-based information about cannabis, MDMA and psilocybin so that they can have meaningful discussions with the military veterans in their care.

Since the panel has members selected by the President and those co-opted by Congressional leaders, analysts say sector companies like Pure Extracts Corp. hope the report will be given the seriousness it deserves and prompt action taken to correct the problems identified.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000